p16 Immunohistochemical Expression in Nephrogenic Adenoma.
| Autor: | Alvarez Moreno JC; Pathology, University of Texas Medical Branch at Galveston, Galveston, USA., Ghani HA; Pathology, University of Texas Medical Branch at Galveston, Galveston, USA., Ovechko V; Pathology, University of Texas Medical Branch at Galveston, Galveston, USA., Clement C; Pathology, University of Texas Medical Branch at Galveston, Galveston, USA., Eyzaguirre E; Pathology, University of Texas Medical Branch at Galveston, Galveston, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Jul 02; Vol. 15 (7), pp. e41285. Date of Electronic Publication: 2023 Jul 02 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.41285 |
| Abstrakt: | Nephrogenic adenoma (NA) is a rare metaplastic entity commonly associated with a prior urothelial injury. Most are seen in the urinary bladder and a minority involve the urethra. In this study, we evaluated the expression of p16 as a surrogate marker of this entity and correlated it with clinical pathological parameters. A total of 17 cases of NA were retrospectively studied to assess the immunohistochemical expression of p16 and its value for the diagnosis of this entity. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Alvarez Moreno et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|